Metabolic & GLP-1

TIRZEPATIDE

Dual GIP/GLP-1 receptor agonist for metabolic research.

Research summary

Studied for

What published work has examined, and the model it used. Not a claim that this compound does any of it for a person, and not a statement about what it is supplied for.

• Body weight in obesity

  Human trials

• Glycaemic control in type 2 diabetes

  Human trials

• Obstructive sleep apnoea

  Human trials

• Heart failure with preserved ejection fraction

  Human trials

• What the GIP receptor contributes

  Animal studies

Size

• 1 vial · 10 mg
• 1 vial · 30 mg
• 1 vial · 60 mg

All products